This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Acme Packet Must Dodge the Falling Anvil

Since that low period of $13.26 it has risen as high as 50% to $20.14 to where it sits today at just under $19. What's its real value? It seems investors have had a hard time justifying the lofty forward multiples absent sustainable growth momentum.

The stock has moved in both directions by as much as 50%. Is there anything to be made of the indecisiveness? Should the drastic correction be interpreted as an overreaction or has the stock now approached its fair market value?

That said, despite its recent drop from $36, the stock is far from being considered cheap as it yet trades at a price-to-earnings ratio of almost 70. Also there are increasing concerns about the competition.

As noted, while Acme has a sizable lead in the session delivery market, no market leader maintains its lead forever -- particularly where it involves prominent rivals such as Cisco (CSCO - Get Report) which has the overall lead in network equipment and routing and switching technology.

Not to be discounted are the technologies from other rivals such as F5 (FFIV), Hewlett-Packard (HPQ) and Riverbed (RVBD) which are all capable of stealing some market share. These fears, coupled with weak carrier spending have caused analysts to revise their estimates lower not only for this year, but also for 2013.

Bottom Line

Acme certainly has a lot to prove and Oct. 25, when it reports earnings, can't come fast enough. While some investors see its recent drop from $36 as an opportunity, I don't think I am yet ready to proclaim value exists. At least not until the company can show that it can grow outside of its reliance on the carriers and/or the carriers start to show more confidence and open up their wallet to buy gear.

On the bright side, carriers can't pull their purse strings forever. Acme is certain to reap the benefits of the cycle once it turns and investors will then be proven right or wrong. In the meantime, Acme is a decent long term hold at the moment.

While I'm not as excited about it as when it was at $13, it is certainly more attractive now than $36.

At the time of publication, the author held no position in any of the stocks mentioned.

This article is commentary by an independent contributor, separate from TheStreet's regular news coverage.
Richard Saintvilus is a private investor with an information technology and engineering background and has been investing and trading for over 15 years. He employs conservative strategies in assessing equities and appraising value while minimizing downside risk. His decisions are based in part on management, growth prospects, return on equity and price-to-earnings as well as macroeconomic factors. He is an investor who seeks opportunities whether on the long or short side and believes in changing positions as information changes.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ADTN $19.89 0.05%
CIEN $16.63 -4.43%
CSCO $27.96 -2.37%
JNPR $23.41 -1.68%
VZ $51.02 -1.30%


Chart of I:DJI
DOW 17,830.76 -210.79 -1.17%
S&P 500 2,075.81 -19.34 -0.92%
NASDAQ 4,805.2910 -57.85 -1.19%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs